Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

Clinical trial NCT01720264 · COMPLETED

Trial details

NCT number: NCT01720264
Sponsor: Sherif S. Farag
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoid Leukemia Hematopoetic Myelodysplasia Leukemia, Myelogenous, Chronic Lymphoma, Non-Hodgkin

Start date: 2012-11-02
Primary completion: 2016-08-27
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.